A Phase 1 study of UCN-01 in combination with irinotecan in patients with resistant solid tumor malignancies. - Fracasso PM; Williams KJ; Chen RC; Picus J; Ma CX; Ellis MJ; Tan BR; Pluard TJ; Adkins DR; Naughton MJ; Rader JS; Arquette MA; et al. (Cancer chemotherapy and pharmacology, 2011)